annb0t
Top 20
ResMed Inc. RMD is gaining from the continued uptake of its sleep and respiratory care devices. The company posted better-than-expected results for the fourth quarter of fiscal 2022. The robust sales performance in the Software as a Service (SaaS) segment is impressive. However, mounting operating costs and macroeconomic headwinds raise apprehensions.
In the past year, the Zacks Rank #3 (Hold) stock has lost 23.7% compared with a 50.4% fall of the industry and a 12.4% decline of the S&P 500.
T...
>>> Read more: Reasons Why You Should Retain ResMed (RMD) Stock For Now
In the past year, the Zacks Rank #3 (Hold) stock has lost 23.7% compared with a 50.4% fall of the industry and a 12.4% decline of the S&P 500.
T...
>>> Read more: Reasons Why You Should Retain ResMed (RMD) Stock For Now
